Jane Street Group, LLC Ocular Therapeutix, Inc Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

A detailed history of Jane Street Group, LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 124,542 shares of OCUL stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
124,542
Previous 194,012 35.81%
Holding current value
$1.06 Million
Previous $1.33 Million 18.39%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$6.45 - $9.23 $448,081 - $641,208
-69,470 Reduced 35.81%
124,542 $1.08 Million
Q2 2024

Aug 14, 2024
SELL
$4.2 - $8.69 $245,044 - $507,009
-58,344 Reduced 23.12%
194,012 $1.33 Million
Q1 2024

May 15, 2024
BUY
$3.85 - $10.93 $466,816 - $1.33 Million
121,251 Added 92.48%
252,356 $2.3 Million
Q4 2023

Feb 14, 2024
BUY
$2.08 - $4.52 $147,141 - $319,749
70,741 Added 117.19%
131,105 $584,000
Q3 2023

Nov 14, 2023
SELL
$3.14 - $5.04 $618,278 - $992,396
-196,904 Reduced 76.54%
60,364 $189,000
Q2 2023

Aug 14, 2023
BUY
$4.6 - $7.64 $645,021 - $1.07 Million
140,222 Added 119.8%
257,268 $1.33 Million
Q1 2023

May 15, 2023
BUY
$2.79 - $6.27 $249,490 - $560,682
89,423 Added 323.73%
117,046 $616,000
Q4 2022

Feb 14, 2023
BUY
$2.61 - $4.41 $12,958 - $21,895
4,965 Added 21.91%
27,623 $77,000
Q3 2022

Nov 14, 2022
SELL
$4.09 - $6.5 $99,329 - $157,859
-24,286 Reduced 51.73%
22,658 $94,000
Q2 2022

Aug 16, 2022
BUY
$3.01 - $5.22 $141,301 - $245,047
46,944 New
46,944 $189,000
Q1 2022

May 17, 2022
SELL
$4.83 - $7.35 $81,506 - $124,031
-16,875 Closed
0 $0
Q4 2021

Feb 15, 2022
SELL
$6.16 - $12.07 $244,441 - $478,961
-39,682 Reduced 70.16%
16,875 $118,000
Q3 2021

Nov 16, 2021
BUY
$9.7 - $14.34 $138,341 - $204,517
14,262 Added 33.72%
56,557 $565,000
Q2 2021

Aug 16, 2021
BUY
$13.43 - $19.16 $14,088 - $20,098
1,049 Added 2.54%
42,295 $599,000
Q1 2021

May 18, 2021
BUY
$15.82 - $22.11 $82,153 - $114,817
5,193 Added 14.4%
41,246 $677,000
Q4 2020

Feb 17, 2021
BUY
$7.91 - $22.95 $46,882 - $136,024
5,927 Added 19.67%
36,053 $746,000
Q3 2020

Nov 17, 2020
BUY
$7.36 - $9.87 $46,713 - $62,644
6,347 Added 26.69%
30,126 $229,000
Q1 2020

May 15, 2020
BUY
$3.95 - $7.4 $93,927 - $175,964
23,779 New
23,779 $118,000
Q3 2018

Nov 14, 2018
SELL
$5.42 - $6.99 $73,110 - $94,288
-13,489 Closed
0 $0
Q2 2018

Aug 15, 2018
BUY
$5.99 - $8.17 $80,799 - $110,205
13,489 New
13,489 $91,000

Others Institutions Holding OCUL

# of Institutions
171
Shares Held
138M
Call Options Held
150K
Put Options Held
225K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $654M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email